Glogene has created a proprietary optimized cell line platform called Glo-CHO™ that facilitates the efficient expression of high-quality antigens and antibodies. The Glo-CHO™ platform is the ideal fusion of a cutting-edge vector and a proprietary CHO-GS cell line, guaranteeing a high-producing cell line for any target molecule. We routinely accomplish highly stable clones’ in few months with 6-10 g/L antibody titer.